Word: dealing
(lookup in dictionary)
(lookup stats)
Dates: during 1990-1999
Sort By: most recent first
(reverse)
...husband to stay at Duke under the care of Drs. Trotter and Tuttle, whom she trusts. When a woman at PHP she believes was Brown finally returned her call Tuesday afternoon on the pay phone near the surgery ward, her message to Kim was that PHP "had a deal" with Duke that if it hadn't transplanted Todd over the weekend, it would move him to unc. "It felt like they were trying to make me doubt the doctors," says...
...that anyone in the business knows that if an insurer "authorizes" a procedure, it means the patient is no longer liable, the hospital will get paid--something. Complicating this particular case is the fact that URN, PHP's liver carrier, has been negotiating with Duke over a liver-capitation deal for months, and neither side wants an individual case to take control of that process...
...Gingrich waits, partly because he wants to, but mostly because he has to, at least until after the election. That's when cutting a deal might start to make sense for him and even for the other side: Gingrich can stop worrying about galvanizing his base, and if he picks up a less-than-expected number of seats--say, only five or six--some in the party can argue it's a message to find a way out of the Lewinsky mess. As for the Democrats, if they lose big, they can go to Clinton with this appeal: "Here...
...danger that we will screw it up the way we normally do, by overplaying our hand and getting too feisty." Carville's assault raised hackles among Democrats in Congress, who do not see much advantage in alienating the very Republicans with whom they may ultimately need to cut a deal. And last week saw the White House disavowing a plan to raise millions for a pro-Clinton advertising campaign at a time when all Democratic dollars are needed to elect candidates...
...recent years. Last fall Duke opened a new 10,000-sq.-ft. laboratory, a set of "clean rooms" where cell cultures can be cultivated in sterile surroundings. The $1.5 million facility was paid for by the pharmaceutical giant Rhone-Poulenc Rorer, based in Collegeville, Pa. But this particular deal is unusual in that the company has no commercial claim on any products developed through the use of the new lab. Sue Strauss is one of 18 Duke patients in Lyerly's trial, one of several vaccine tests approved by the Food and Drug Administration...